The Impact of Industry Funding on Randomized Controlled Trials of Biologic Therapies

Background: There has been substantial interest from the pharmaceutical industry to study and develop new biologic agents. Previous studies outside of the biologics field have demonstrated that industry funding has the potential to impact the design and findings of clinical trials. The objective of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gazendam, Aaron M., Slawaska-Eng, David, Nucci, Nicholas, Bhatt, Om, Ghert, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951352/
https://www.ncbi.nlm.nih.gov/pubmed/35323717
http://dx.doi.org/10.3390/medicines9030018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951352/
https://www.ncbi.nlm.nih.gov/pubmed/35323717
http://dx.doi.org/10.3390/medicines9030018

Ejemplares similares